- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | SciBase receives additional order from Castle Biosciences, advancing the collaboration | 246 | PR Newswire | STOCKHOLM, Sept. 8, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has... ► Artikel lesen | |
| Di | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.09.2026 | 317 | Xetra Newsboard | Das Instrument 7M8 SE0003273531 ECORUB AB B EQUITY wird cum Kapitalmassnahme gehandelt am 08.09.2026 und ex Kapitalmassnahme am 09.09.2026 The instrument 7M8 SE0003273531 ECORUB AB B EQUITY is traded... ► Artikel lesen | |
| 03.09. | SciBase Resolves On A Rights Issue Of Shares Of Approximately Sek 58 Million | 412 | PR Newswire | STOCKHOLM, Sept. 3, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, pursuant to the authorisation granted by the annual general... ► Artikel lesen | |
| 19.08. | SciBase: Interim report | 359 | PR Newswire | STOCKHOLM, Aug. 19, 2026 /PRNewswire/ --
January 1 - June 30, 2026The second quarter in figures Net sales were TSEK 15,308 (8,791), +74%, cleared for currency effects +84%. ... ► Artikel lesen | |
| 28.07. | SciBase announces changes in senior management | 416 | PR Newswire | STOCKHOLM, July 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB) a leader in AI-based devices for detection and prevention in dermatology, today announced that Pia Renaudin... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 01.07. | SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market | 523 | PR Newswire | STOCKHOLM, July 1, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB) a leader in AI-based devices for detection and prevention in dermatology, today announced the submission... ► Artikel lesen | |
| 10.06. | First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase | 493 | PR Newswire | STOCKHOLM, June 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced that the first patient has been... ► Artikel lesen | |
| 09.06. | SciBase: Study that highlights Nevisense potential for prediction of AD published in leading journal | 431 | PR Newswire | STOCKHOLM, June 9, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced the publication of a study in... ► Artikel lesen | |
| 04.06. | XFRA NEW INSTRUMENTS AVAILABLE ON 04.06.2026 | 415 | Xetra Newsboard | The following instruments on XETRA do have their first trading 04.06.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 04.06.2026
Aktien
1 US53229X1019 Liftoff Mobile Inc.
2... ► Artikel lesen | |
| 03.06. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 03.06.2026 | 765 | Xetra Newsboard | Deletion of Instruments from Boerse Frankfurt - 03.06.2026The following instruments on Boerse Frankfurt do have their last trading day on 03.06.2026.Die folgenden Instrumente in Boerse Frankfurt haben... ► Artikel lesen | |
| 03.06. | XFRA ISIN CHANGE | 413 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA03820A1093 Bullfrog Gold Corp. 03.06.2026 CA12022T1057 Bullfrog Gold Corp. 04.06.2026 Tausch 1:1SE0007045414 SciBase... ► Artikel lesen | |
| 03.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.06.2026 | 552 | Xetra Newsboard | Das Instrument 7V3 SE0006371126 CANTARGIA AB EQUITY wird ex Kapitalmassnahme gehandelt am 03.06.2026 The instrument 7V3 SE0006371126 CANTARGIA AB EQUITY is traded ex capital adjustment on 03.06.2026Das... ► Artikel lesen | |
| 02.06. | Split and Change of ISIN for Scibase Holding AB | 232 | GlobeNewswire | The company will carry out a reverse stock split in a ratio of 1:100. The share will be traded under new ISIN code with effect from Jun 4, 2026. The order book will not change.
Short... ► Artikel lesen | |
| 28.05. | SciBase announces that the board of directors has resolved on the record date for the reverse share split | 576 | PR Newswire | STOCKHOLM, May 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that the board... ► Artikel lesen | |
| 28.05. | SciBase: Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study | 535 | PR Newswire | STOCKHOLM, May 28, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, announced today the publication... ► Artikel lesen | |
| 19.05. | Bulletin from the annual general meeting in SciBase Holding AB (publ) | 409 | PR Newswire | STOCKHOLM, May 19, 2026 /PRNewswire/ -- Today, the annual general meeting 2026 has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 18.05. | SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes | 456 | PR Newswire | STOCKHOLM, May 18, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced the presentation... ► Artikel lesen | |
| 07.05. | Scibase Holding AB: Interim report | 268 | GlobeNewswire (Europe) | January 1 - March 31, 2026
The first quarter in figures
Net sales were TSEK 14,278 (8,856), +61%, cleared for currency effects +80%.
The loss after tax was TSEK 24,490 (20,682).
The loss per share... ► Artikel lesen | |
| 27.04. | SciBase publishes the Annual report for 2025 | 439 | PR Newswire | STOCKHOLM, April 27, 2026 /PRNewswire/ -- SciBase hereby announces that the Annual report for 2025 is available at the Company's website www.scibase.com.
A pdf-version of the annual... ► Artikel lesen | |
| 14.04. | Notice to attend the annual general meeting in Scibase Holding AB (publ) | 3 | Cision News |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,085 | -4,06 % | Stocks in Play: Sernova Biotherapeutics | ||
| BOSTON SCIENTIFIC | 37,500 | +1,02 % | Aktien New York Ausblick: Dow schwächelt weiter - Nasdaq stabil erwartet | NEW YORK (dpa-AFX) - Die US-Börsen steuern nach dem verlängerten Wochenende am Dienstag auf eine durchwachsene Eröffnung zu. Auf die Stimmung drückten die weiter steigenden Ölpreise, die der Angst... ► Artikel lesen | |
| PAUL HARTMANN | 201,00 | +0,50 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 9,830 | +1,07 % | Sysmex Europe SE and Cytek Biosciences, Inc. Collaborate to Expand Access to Advanced Clinical Flow Cytometry | FREMONT, Calif., and HAMBURG, Germany, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysmex Europe SE, a leader in diagnostic and healthcare solutions, and Cytek Biosciences, Inc. (Nasdaq: CTKB), a leader in spectral... ► Artikel lesen | |
| EMBECTA | 4,744 | +12,52 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ADDLIFE | 13,490 | -3,78 % | AddLife AB: AddLife acquires Unicam Sistemas Analíticos Lda | AddLife has acquired Unicam Sistemas Analíticos, a leading Portuguese distributor of advanced analytical laboratory equipment. The company will be included within AddLife's Business Area Labtech.Unicam... ► Artikel lesen | |
| ENOVIS | 16,200 | +1,89 % | Enovis auf Wells-Fargo-Konferenz: Robotik-Strategie rückt in den Mittelpunkt | ||
| PULMONX | 1,600 | 0,00 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| SI-BONE | 15,400 | 0,00 % | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance | Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period)... ► Artikel lesen | |
| KOOTH | 2,040 | 0,00 % | Kooth PLC - Notice of Half Year Results | ||
| PEIJIA MEDICAL | 0,488 | -1,61 % | Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth | SUZHOU, China, Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| LIFECARE ASA | 0,011 | -57,85 % | OCEAN GEOLOOP ASA: Captured AS enters into agreement to sell its shares in its subsidiary Ocean Tunicell AS to Lifecare ASA | ||
| BACTIGUARD | 1,285 | 0,00 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| PHC HOLDINGS | 6,650 | -1,48 % | PHC Holdings Corporation: Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership | A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,88 | 0,00 % | BrightSpring auf Wells Fargo Konferenz: Wachstum beschleunigt sich auf breiter Front |
SCIBASE HOLDING AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,505 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.